Clinical efficacy of two cardiac troponin i assays

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 8, 2009, Pages 1013-1015

  Dupuy, Anne Marie ^a   Bouvier, Sylvie ^a   Bargnoux, Anne Sophie ^a   Badiou, Stéphanie ^a   Cristol, Jean Paul ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

99th percentile reference limit; Cardiac troponin I (cTnI); Method comparison

Indexed keywords

TROPONIN I;

ACUTE HEART INFARCTION; ANALYZER; ARCHITECT I1000SR; ARCHITECT I2000SR; FALSE NEGATIVE RESULT; FREQUENCY ANALYZER; HUMAN; INTERMETHOD COMPARISON; LETTER; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUALITY CONTROL; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION;

CHEMILUMINESCENT MEASUREMENTS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; MYOCARDIUM; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 70349478738     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.226     Document Type: Letter

References (10)

1. James S, Flodin M, Johnston N, Lindahl B, Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006; 52:832-837
2. NCCLS. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. NCCLS document EP17-A (ISBN 1-56238-551-8). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-21898 USA, 2004.
3. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160
4. Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996;33:1-4.
5. NACB Writing Group Members, Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes. Circulation 2007;115:e352-5.
6. Apple F, Murakami M. The diagnostic utility of cardiac biomarkers in detecting myocardial infarction. Clin Cornerstone 2005;7:S25-30.
7. Boulier A, Jaussent I, Terrier N, Maurice F, Rivory JP, Chalabi L, et al. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients. Nephrol Dial Transpl 2004;19: 2313-2318
8. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
9. Wu AH. Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series. Clin Chim Acta 2009;401:170-174
10. Storti S, Prontera C, Serena Parri M, Iervasi A, Vittorini S, Emdin M, et al. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. Clin Chem Lab Med 2006;44: 1022-1029